1-Chloro-3,5-dimethyladamantane – (707-36-8)

4-aminobenzamidine, p-Aminobenzamidine, 3858-83-1, 4-Aminobenzenecarboximidamide, 4-aminobenzimidamide, Benzenecarboximidamide, 4-amino-, Benzamidine, p-amino-, EINECS 223-370-7, 4-Amino-benzamidine, NSC 227928, BRN 0386209, 63GK9KT599, NSC-227928, 4-AMINOBENZENE-1-CARBOXIMIDAMIDE, CHEMBL124632, DTXSID30191899, para-aminobenzamidine, p-Aminobenzamidine (dihydrochloride), UNII-63GK9KT599, Lopac-A-7148, Lopac0_000070, 1329499-33-3, ABD, SCHEMBL150756, WPANETAWYGDRLL-UHFFFAOYSA-, DTXCID20114390, BBL007616, BDBM50092660, NSC227928, STK367857, AKOS005444850, Benzenecarboximidamide, 4-amino-(9CI), CCG-204165, SDCCGSBI-0050058.P002, NCGC00015084-01, NCGC00015084-02, NCGC00015084-03, NCGC00015084-04, NCGC00015084-05, NCGC00162057-01, DA-17009, (6S)-Tetrahydro-L-biopterin-d3 Disulfate, CS-0165920, NS00030422, EN300-70197, AB00374717-08, 4-aminobenzimidamide? (Dabigatran Impurity pound(c), Q27263611, InChI=1/C7H9N3/c8-6-3-1-5(2-4-6)7(9)10/h1-4H, 8H2, (H3, 9, 10), 223-370-7